ALXN

Alexion Pharmaceuticals Inc
ALXN

Overview Fund Activity
Delisted

ALXN was delisted on the 20th of July, 2021.

Back to rankings

665 hedge funds and large institutions have $22B invested in Alexion Pharmaceuticals Inc in 2019 Q4 according to their latest regulatory filings, with 100 funds opening new positions, 248 increasing their positions, 237 reducing their positions, and 66 closing their positions.

Holders
665
Holders Change
+20
Holders Change %
+3.1%
% of All Funds
13.13%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.32%
New
100
Increased
248
Reduced
237
Closed
66
Calls
$214M
Puts
$394M
Net Calls
-$180M
Net Calls Change
-$80.8M

Top Buyers

1
AQR Capital Management
1
AQR Capital Management
Connecticut
$255M
2
Renaissance Technologies
2
Renaissance Technologies
New York
$404M
3
Bank of Montreal
3
Bank of Montreal
Ontario, Canada
$147M
4
CS
4
Credit Suisse
Switzerland
$298M
5
UBS Group
5
UBS Group
Switzerland
$144M

Top Sellers

1
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.59B
2
Invesco
2
Invesco
Georgia
$170M
3
Artisan Partners
3
Artisan Partners
Wisconsin
$357M
4
SSM
4
Sound Shore Management
Connecticut
$0
5
RG
5
Redmile Group
California
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Wells Fargo
26
Wells Fargo
California
$179M 1,655,191 -273,588 -14%
Invesco
27
Invesco
Georgia
$170M 1,567,693 -1,873,516 -54%
Deutsche Bank
28
Deutsche Bank
Germany
$168M 1,556,804 +47,099 +3%
Nuveen Asset Management
29
Nuveen Asset Management
Illinois
$164M 1,516,149 +295,356 +24%
Manulife (Manufacturers Life Insurance)
30
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$156M 1,444,940 +82,008 +6%
Charles Schwab
31
Charles Schwab
California
$152M 1,402,284 +115,764 +9%
Neuberger Berman Group
32
Neuberger Berman Group
New York
$152M 1,401,631 -154,455 -10%
BG
33
Bellevue Group
Switzerland
$150M 1,388,928 +22,400 +2%
Bank of Montreal
34
Bank of Montreal
Ontario, Canada
$147M 1,355,105 +878,551 +184%
UBS Group
35
UBS Group
Switzerland
$144M 1,334,393 +746,516 +127%
Legal & General Group
36
Legal & General Group
United Kingdom
$144M 1,331,558 +54,648 +4%
AllianceBernstein
37
AllianceBernstein
Tennessee
$134M 1,240,036 +116,386 +10%
PHS
38
PFM Health Sciences
California
$116M 1,076,442 -370,170 -26%
Morgan Stanley
39
Morgan Stanley
New York
$107M 987,853 +406,580 +70%
Sumitomo Mitsui Trust Group
40
Sumitomo Mitsui Trust Group
Japan
$97.6M 902,674 -37,770 -4%
Fidelity International
41
Fidelity International
Bermuda
$95.7M 884,450 -319,455 -27%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$95.6M 884,209 -752,592 -46%
PAI
43
Palo Alto Investors
California
$95M 878,100 -79,850 -8%
CCM
44
Camber Capital Management
Massachusetts
$94.6M 875,000 +25,000 +3%
First Trust Advisors
45
First Trust Advisors
Illinois
$91.7M 847,845 +187,762 +28%
Man Group
46
Man Group
United Kingdom
$90.5M 837,053 +323,949 +63%
Dimensional Fund Advisors
47
Dimensional Fund Advisors
Texas
$89.9M 831,721 +127,370 +18%
PAMU
48
Pictet Asset Management (UK)
United Kingdom
$89.7M 829,231 -96,535 -10%
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$87.5M 809,110 +242,148 +43%
AAMU
50
Amundi Asset Management US
Massachusetts
$82.6M 763,524 +268,839 +54%
1
2
3 4 5